Market Snapshot

BSE Sensex: 75237.99 -0.21%
BSE 500: 35236.5 -0.36%
BSE 200: 10986.48 -0.35%
BSE 100: 25051.12 -0.28%
BSE BANKEX: 60489.34 -0.77%
BSE IT: 26964.26 1.06%
Nifty 50: 23643.5 -0.19%
Nifty 500: 22531.15 -0.36%
Nifty 200: 13596.35 -0.36%
Nifty 100: 24572.15 -0.33%
Nifty Midcap 100: 60567.15 -0.45%
Nifty Small 100: 17882.6 -0.61%
Nifty IT: 27716.9 1.30%
Nifty PSU Bank: 8027.2 -1.80%

News:

Azad Engineering Q4 PAT climbs...
Atul Auto Q4 PAT surges 107% Y...
SAIL reports 43% surge in Q4 P...
Greenpanel Industries clocks P...
Shriram Asset Management Compa...

Anthem Biosciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

15 May 2026 | 03:59 PM

783.50

-34.95 (-4.27%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

0%

Return (1Y)

Underperformed BSE Healthcare by 10.88%
More Volatile

2.06%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.22%
Not so consistent

6/11

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

873

579

News & Announcements

Anthem Biosciences to hold board meeting
4 days ago

Anthem Biosciences to hold board meeting

13 - May - 2026 12:00 | 4 days ago

Anthem Biosciences will hold a meeting of the Board of Directors of the Company on 19 May 2026.
Anthem Biosciences allots 1.03 lakh equity shares under ESOP
101 days ago

Anthem Biosciences allots 1.03 lakh equity shares under ESOP

05 - Feb - 2026 12:00 | 101 days ago

Anthem Biosciences has allotted 1,03,800 equity shares under ESOP on 05 February 2026. Consequent to this allotment, the paid-up equity share capital of the Company stand increased from Rs. 1,12,32,20,102/- (consisting of 56,16,10,051 equity shares of face value of Rs. 2 each) to Rs. 1,12,34,27,702/- (consisting of 56,17,13,851 equity shares of face value of Rs. 2 each).
Powered by Capital Market - Live News
Anthem Biosciences consolidated net profit declines 25.34% in the December 2025 quarter
101 days ago

Anthem Biosciences consolidated net profit declines 25.34% in the December 2025 quarter

05 - Feb - 2026 12:00 | 101 days ago

Net profit of Anthem Biosciences declined 25.34% to Rs 92.82 crore in the quarter ended December 2025 as against Rs 124.33 crore during the previous quarter ended December 2024. Sales declined 15.00% to Rs 423.15 crore in the quarter ended December 2025 as against Rs 497.81 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 423.15 497.81 -15

OPM % 37.15 32.04 -

PBDT 190.38 181.33 5

PBT 155.84 161.05 -3

NP 92.82 124.33 -25

Powered by Capital Market - Live News
Anthem Biosciences to announce Quarterly Result
109 days ago

Anthem Biosciences to announce Quarterly Result

28 - Jan - 2026 12:00 | 109 days ago

Anthem Biosciences will hold a meeting of the Board of Directors of the Company on 5 February 2026.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Anthem Biosciences Ltd has decreased by -6.11% since past 3 Months
MF shareholding in Anthem Biosciences Ltd has increased by 46.84% since past 3 Months
Promoter shareholding in Anthem Biosciences Ltd has decreased by -3.3% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	423.15	497.81	-15
OPM %	37.15	32.04	-
PBDT	190.38	181.33	5
PBT	155.84	161.05	-3
NP	92.82	124.33	-25

General Notifications

My Notifications

Research Notifications

Anthem Biosciences Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

783.50 -34.95 (-4.27%)

News & Announcements

Price vs Volume

Stock Trivia

Anthem Biosciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

783.50

-34.95 (-4.27%)